These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 21712239)

  • 1. PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates.
    Solomon K; Fanning S; McDermott S; Murray S; Scott L; Martin A; Skally M; Burns K; Kuijper E; Fitzpatrick F; Fenelon L; Kyne L
    J Antimicrob Chemother; 2011 Sep; 66(9):1976-82. PubMed ID: 21712239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018.
    Spigaglia P; Barbanti F; Dionisi AM; Mastrantonio P
    J Clin Microbiol; 2010 Aug; 48(8):2892-6. PubMed ID: 20554809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and association of PCR ribotypes of Clostridium difficile isolated from symptomatic patients from Warsaw with macrolide-lincosamide-streptogramin B (MLSB) type resistance.
    Pituch H; Brazier JS; Obuch-Woszczatyński P; Wultańska D; Meisel-Mikołajczyk F; Łuczak M
    J Med Microbiol; 2006 Feb; 55(Pt 2):207-213. PubMed ID: 16434714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of Clostridium difficile in Scotland.
    Wiuff C; Brown DJ; Mather H; Banks AL; Eastaway A; Coia JE
    J Infect; 2011 Apr; 62(4):271-9. PubMed ID: 21300104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes.
    Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren AC; Weintraub A; Nord CE
    Int J Antimicrob Agents; 2009 Apr; 33(4):339-42. PubMed ID: 19097757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile.
    Drudy D; Quinn T; O'Mahony R; Kyne L; O'Gaora P; Fanning S
    J Antimicrob Chemother; 2006 Dec; 58(6):1264-7. PubMed ID: 17018563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of macrolide-lincosamide-streptogramin B (MLS(B)) resistance determinant in strains of Clostridium difficile.
    Spigaglia P; Mastrantonio P
    Microb Drug Resist; 2002; 8(1):45-53. PubMed ID: 12002649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile.
    Ackermann G; Degner A; Cohen SH; Silva J; Rodloff AC
    J Antimicrob Chemother; 2003 Mar; 51(3):599-603. PubMed ID: 12615860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfer of Clostridium difficile Genetic Elements Conferring Resistance to Macrolide-Lincosamide-Streptogramin B (MLSB) Antibiotics.
    Barbanti F; Wasels F; Spigaglia P
    Methods Mol Biol; 2016; 1476():187-98. PubMed ID: 27507342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity of moxifloxacin resistance during a nosocomial outbreak of a predominantly ribotype ARU 027 Clostridium difficile diarrhea.
    Carman RJ; Genheimer CW; Rafii F; Park M; Hiltonsmith MF; Lyerly DM
    Anaerobe; 2009 Dec; 15(6):244-8. PubMed ID: 19818865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis.
    Nyc O; Tejkalova R; Kriz Z; Ruzicka F; Kubicek L; Matejkova J; Kuijper E; Krutova M
    Microb Drug Resist; 2017 Jul; 23(5):609-615. PubMed ID: 27860531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].
    Poilane I; Fantinato C; Cruaud P; Collignon A
    Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter- and intraspecies transfer of a Clostridium difficile conjugative transposon conferring resistance to MLSB.
    Wasels F; Monot M; Spigaglia P; Barbanti F; Ma L; Bouchier C; Dupuy B; Mastrantonio P
    Microb Drug Resist; 2014 Dec; 20(6):555-60. PubMed ID: 25055190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between PCR ribotypes and antimicrobial susceptibility among Clostridium difficile isolates from healthcare-associated infections in South Korea.
    Kim J; Kang JO; Pai H; Choi TY
    Int J Antimicrob Agents; 2012 Jul; 40(1):24-9. PubMed ID: 22578765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of an outbreak of diarrhoea in a vascular surgery unit caused by a high-level clindamycin-resistant Clostridium difficile PCR ribotype 106.
    Ratnayake L; McEwen J; Henderson N; Nathwani D; Phillips G; Brown D; Coia J
    J Hosp Infect; 2011 Nov; 79(3):242-7. PubMed ID: 21864938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm.
    Huang H; Fang H; Weintraub A; Nord CE
    Clin Microbiol Infect; 2009 Dec; 15(12):1170-3. PubMed ID: 19624517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide-lincosamide-streptogramin B resistance phenotypes in clinical staphylococcal isolates.
    Cetin ES; Gunes H; Kaya S; Aridogan BC; Demirci M
    Int J Antimicrob Agents; 2008 Apr; 31(4):364-8. PubMed ID: 18206352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolates.
    Walkty A; Boyd DA; Gravel D; Hutchinson J; McGeer A; Moore D; Simor A; Suh K; Taylor G; Miller M; Mulvey MR;
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):419-24. PubMed ID: 20226332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals.
    Johnson S; Samore MH; Farrow KA; Killgore GE; Tenover FC; Lyras D; Rood JI; DeGirolami P; Baltch AL; Rafferty ME; Pear SM; Gerding DN
    N Engl J Med; 1999 Nov; 341(22):1645-51. PubMed ID: 10572152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.
    Lachowicz D; Pituch H; Obuch-Woszczatyński P
    Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.